Gastrointestinal Concerns Which Respond Well to Integrative Therapy
We assist individuals diagnosed with numerous gastrointestinal diseases, disorders, syndromes which often have not responded well to other therapies.
The following is a brief list of common gastrointestinal ailments we frequently see here at Atlanta Integrative Medicine. By no means is this exhaustive; please contact the clinic directly if you have a question about a specific diagnosis or condition not listed below:
- IBD and IBS
- Gastritis and gastric ulcers
- Indigestion, gas, bloating
- Poor digestion and assimilation
- Poor/excessive appetite
- Hepatitis (A, B, C, D, autoimmune and others)
- Gastrointestinal disease prevention and wellness
Gut bacteria may affect your weight
Something in your gut could be making you fat — and it isn’t just last night’s pizza.
The vast, diverse community of microbes inhabiting the intestines, scientists are finding, can influence metabolism and weight. http://articles.latimes.com/2010/jun/21/health/la-he-in-the-works-20100621
FDA Issues Warning About Proton Pump Inhibitors
The FDA is warning physicians and consumers about a possible increased risk for fractures of the hip, wrist and spine with high doses or long-term use of proton pump inhibitors, or PPIs.
The labeling on these products will be changed to describe these risks for both the prescription and OTC product versions, the agency said.
World J Gastroenterol. 2007 Jan 7;13(1):146-51.
Malignancy and mortality in a population-based cohort of patients with 1eliac disease or “gluten sensitivity”. Anderson LA, McMillan SA, Watson RG, Monaghan P, Gavin AT, Fox C, Murray LJ.
Centre for Clinical and Population Sciences, Mulhouse Building, Grosvenor Road, Belfast, BT12 6BJ, United Kingdom, firstname.lastname@example.org.
To determine the risk of malignancy and mortality in patients with a positive endomysial or anti-gliadin antibody test in Northern Ireland.
A population-based retrospective cohort study design was used. Laboratory test results used in the diagnosis of 1eliac disease were obtained from the Regional Immunology Laboratory, cancer statistics from the Northern Ireland Cancer Registry and mortality statistics from the General Registrar Office, Northern Ireland. Age standardized incidence ratios of malignant neoplasms and standardized mortality ratios of all-cause and cause-specific mortality were calculated.
A total of 13 338 people had an endomysial antibody and/or an anti-gliadin antibody test in Northern Ireland between 1993 and 1996. There were 490 patients who tested positive for endomysial antibodies and they were assumed to have 1eliac disease. There were 1133 patients who tested positive for anti-gliadin antibodies and they were defined as gluten sensitive. Malignant neoplasms were not significantly associated with 1eliac disease; however, all-cause mortality was significantly increased following diagnosis. The standardized incidence and mortality ratios for non-Hodgkin’s lymphoma were increased in 1eliac disease patients but did not reach statistical significance. Lung and breast cancer incidence were significantly lower and all-cause mortality, mortality from malignant neoplasms, non-Hodgkin’s lymphoma and digestive system disorders were significantly higher in gluten sensitive patients compared to the Northern Ireland population.
Patients with 1eliac disease or gluten sensitivity had higher mortality rates than the Northern Ireland population. This association persists more than one year after diagnosis in patients testing positive for anti-gliadin antibodies. Breast cancer is significantly reduced in the cohort of patients with gluten sensitivity.
IBD AND IBS
Splenda Can Destroy Your Immune System and is Like Eating an Insecticide
In early studies of inflammatory bowel disease (IBD), it was shown to be most prevalent in countries such as the United Kingdom, the United States and those in northern Europe.
However, in more recent studies, Canada has suddenly shot to the top of the list as the country with the highest incidence.
PREVENTION AND WELLNESS
Metabolomics and the Microbiome (MWV45)
In episode 45 of MicrobeWorld Video, filmed at the American Association for the Advancement of Science Meeting in Washington, D.C., Dr. Stan Maloy talks with Jeremy Nicholson, Head of the Department of Surgery & Cancer at Imperial College London, about his work with metabolomics and the human gut.
VIENNA, W.Va. — Exposure to C8 is probably linked to thyroid disease and to an inflammatory bowel disease called ulcerative colitis, according to the latest findings of a scientific team that is investigating the DuPont Co. chemical’s potential impacts on human health.
The C8 Science Panel’s report adds to conclusions of the group, which had already reported a “probable link” between C8 exposure and types of cancer and to dangerous high blood pressure among pregnant women.